32541 Pharmaceutical and Medicine Manufacturing
This industry comprises establishments primarily engaged in one or more of the following: (1) manufacturing biological and medicinal products; (2) processing (i.e., grading, grinding, and milling) botanical drugs and herbs; (3) isolating active medicinal principals from botanical drugs and herbs; and (4) manufacturing pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Where 32541 sits in the NAICS 2022 hierarchy
- >31-33 Manufacturing
- >>325 Chemical Manufacturing
- >>>3254 Pharmaceutical and Medicine Manufacturing
- >>>>32541 Pharmaceutical and Medicine Manufacturing
- >>>>32541 Pharmaceutical and Medicine Manufacturing
Subcategories of 32541 Pharmaceutical and Medicine Manufacturing
- 325411Medicinal and Botanical Manufacturing
This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals. Cross-References. Establishments primarily engaged in--
- 325412Pharmaceutical Preparation Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--
- 325413In-Vitro Diagnostic Substance Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.
- 325414Biological Product (except Diagnostic) Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic). Cross-References. Establishments primarily engaged in--
Frequently asked questions
- What is NAICS 2022 32541?
- NAICS 2022 32541 is "Pharmaceutical and Medicine Manufacturing". This industry comprises establishments primarily engaged in one or more of the following: (1) manufacturing biological and medicinal products; (2) processing (i.e., grading, grinding, and milling) botanical drugs and herbs; (3) isolating active medicinal principals from botanical drugs and herbs; and (4) manufacturing pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- What does NAICS 2022 32541 include?
- 32541 Pharmaceutical and Medicine Manufacturing contains 4 direct subcategories: 325411 Medicinal and Botanical Manufacturing; 325412 Pharmaceutical Preparation Manufacturing; 325413 In-Vitro Diagnostic Substance Manufacturing; 325414 Biological Product (except Diagnostic) Manufacturing.
- What is the parent category of 32541?
- 32541 Pharmaceutical and Medicine Manufacturing sits under 32541 Pharmaceutical and Medicine Manufacturing in the NAICS 2022 hierarchy.
Classify my business
Describe your business in plain English and get matching codes across NAICS 2022 and other major systems.
Interactive browser
Open 32541 in the full interactive explorer with tree view, search, and drill-downs.